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Abstract
Background: Much of the research on decision-making in health care has focused on consultation outcomes.
Less is known about the process by which clinicians and patients come to a treatment decision. This study aimed
to quantitatively describe the behaviour shown by doctors and patients during primary care consultations when
three types of decision aids were used to promote treatment decision-making in a randomised controlled trial.
Methods: A video-based study set in an efficacy trial which compared the use of paper-based guidelines (control)
with two forms of computer-based decision aids (implicit and explicit versions of DARTS II). Treatment decision
concerned warfarin anti-coagulation to reduce the risk of stroke in older patients with atrial fibrillation. Twenty
nine consultations were video-recorded. A ten-minute 'slice' of the consultation was sampled for detailed content
analysis using existing interaction analysis protocols for verbal behaviour and ethological techniques for non-
verbal behaviour.
Results: Median consultation times (quartiles) differed significantly depending on the technology used. Paper-
based guidelines took 21 (19–26) minutes to work through compared to 31 (16–41) minutes for the implicit tool;
and 44 (39–55) minutes for the explicit tool. In the ten minutes immediately preceding the decision point, GPs
dominated the conversation, accounting for 64% (58–66%) of all utterances and this trend was similar across all
three arms of the trial. Information-giving was the most frequent activity for both GPs and patients, although GPs
did this at twice the rate compared to patients and at higher rates in consultations involving computerised
decision aids. GPs' language was highly technically focused and just 7% of their conversation was socio-emotional
in content; this was half the socio-emotional content shown by patients (15%). However, frequent head nodding
and a close mirroring in the direction of eye-gaze suggested that both parties were active participants in the
conversation
Conclusion: Irrespective of the arm of the trial, both patients' and GPs' behaviour showed that they were
reciprocally engaged in these consultations. However, even in consultations aimed at promoting shared decision-
making, GPs' were verbally dominant, and they worked primarily as information providers for patients. In addition,
computer-based decision aids significantly prolonged the consultations, particularly the later phases. These data
suggest that decision aids may not lead to more 'sharing' in treatment decision-making and that, in their current
form, they may take too long to negotiate for use in routine primary care.
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Background
Clinicians increasingly recognise the importance of engag-
ing patients in health care especially where decisions
about treatment have significant effects on quality of life
or where there are choices between alternative therapies
with differing risks and benefits [1,2]. Indeed for ethical
reasons, patients' autonomous authorization of medical
interventions (informed consent) is usually required
before treatment can or should occur [3]. In primary care,
increased patient engagement in health care is reflected in
a range of interventions aimed at developing patient-cen-
tred approaches during consultations which take into
account patients' needs and anxieties concerning treat-
ment [4,5]. Such approaches sit well with the acknowl-
edgement that diagnostic uncertainty is common for
primary care clinicians [6,7] and that patients are experts
regarding the experience of their health condition with
legitimate preferences for differing health states, treat-
ments and outcomes [8].
Until recently, research on patient-centred approaches
tended to focus on promoting a joint understanding of
patients' problems which generally occurs earlier in the
diagnostic stages of a consultation [9]. Less emphasis was
placed on treatment decision-making which tends to
occur later in the consultation. However, the requirement
for informed consent for medical treatment [3], coupled
with the fact that increasing numbers of patients expect to
be involved in decisions about their care [10], has led to
the development of numerous patient decision aids
aimed at promoting shared decision-making. Shared deci-
sion-making has been defined as a collaborative endeav-
our in which:
'both patient and doctor have a legitimate investment in
the treatment decision; hence both declare treatment pref-
erences and their rationale while trying to build consensus
on the appropriate treatment to apply' [11]
There has been a prolific expansion in patient decision
aids aiming to promote shared decision-making over the
past 10 years which has been aided by recent technologi-
cal advancements in health care, and so patient decision
aids now take on a wide range of forms from written pam-
phlets to interactive computer programmes [12,13]. Most
of the evaluative work on decision aids has looked at con-
sultation outcomes and found that they can improve
patients' knowledge about a condition and reduce deci-
sion conflict about treatment; although they have had a
variable impact on the actual decisions made and on sat-
isfaction with treatment [14]. However, treatment deci-
sion-making is complex and dynamic and there can be
many shifts and changes in clinicians' and patients' style
of involvement in a discussion and/or use of a decision
aid as a consultation proceeds [15]. Relatively little is
known about the impact of decision aids on the format,
trajectory and style of consultations. The ease, or con-
versely unease, with which technologies like decision aids
are embedded in practice is important since patients' per-
ceptions about the quality of health care communication
within consultations can affect their health and even their
prognostic outcomes after treatments [16,17].
Thus we need to understand how decision aids are actu-
ally used by clinicians and patients in health care [10]
including their impact on the content and timing of the
consultation. Given the variety of forms that decision aids
can take, it is also essential to assess the relative impact
that different technologies might have on the course of
the clinical encounter [18].
The aim of this study was to quantitatively describe the
impact of three types of decision aid on the duration and
content of consultations focused on treatment decision-
making in primary care. This quantitative observational
work was part of a larger mixed-method (video and inter-
view-based) process study of a randomised controlled
trial. The parent trial aimed to promote decision making
in primary care via the use of three arms: two computer-
ised patient decision aids delivered in a shared decision
making consultation; and a control condition of paper-
based guidelines applied in a paternalistic way as a source
of doctor-led advice. In the process study, we did not
begin with a specific hypothesis concerning the impact of
these decision aids on the consultation. In line with the
qualitative research tradition, we wished to inductively
identify and describe the differences in interactional
behaviour between the three arms. However, this
involved two informal hypotheses. (i) that differences in
the three arms of the trial would lead to differently struc-
tured interactions between participants, and (ii) that the
use of technology in the decision aid arms would affect
the inter-personal communication.
The observational component of the process study
reported in this paper involved a detailed interaction anal-
ysis of consultation behaviour using numeric data to facil-
itate comparison between three different arms of the trial.
This observational work was informed by the precepts of
ethology: non-participant observation of subjects in a nat-
uralistic context accompanied by systematic data sam-
pling and analysis of manifest behaviour [19]. This
naturalistic approach to the study of behaviour avoids
imposing a priori conceptualizations on the target activity
and is compatible with grounded theory approaches to
research [20,21].
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Methods
Trial context
The parent trial was an efficacy study of the use of the
computerised patient decision aids [22] in primary care
consultations. The patient decision aids were designed to
support decision-making concerning warfarin anticoagu-
lation or aspirin treatment to reduce the risk of stroke in
patients with atrial fibrillation [23,22]. There were two
versions: the implicit (concise) patient decision aid
involves individualised risk and benefit presentation and
a section to support shared decision-making; the explicit
(extended) patient decision aid additionally includes
patients' elicited values for health and treatment states
derived via standard gamble and analysed in a Markov
decision analysis [23]. This latter version therefore incor-
porated not only personalised risk and benefit data, but
also derived personal values (utilities) for the relevant
health states which were used in a decision analysis. The
output of the decision analysis was presented to the
patient to support the shared decision making section of
the consultation.
The three armed trial sought to determine whether the
two versions of the computerised decision aid, applied in
the context of shared decision-making, were efficacious at
reducing decisional conflict compared to a control condi-
tion of paper-based clinical guidelines derived from the
same decision analysis and applied as a doctor-led source
of advice. In each arm of the trial, a single male GP admin-
istered one version of the decision aid. These three GPs
were familiar with their version of decision aid and
trained to deliver it in as close to optimum conditions as
possible. Patients were randomly allocated to the three
arms of the trial and experienced only one form of deci-
sion aid. Consultations in this trial acted as referral clinics;
any decisions made were forwarded to the participants'
own GP who retained overall clinical responsibility. The
trial GPs were therefore not the patients' usual GP, nor
were clinics held in their usual surgeries.
The process study
The process study was carried out between January 2003
and April 2004 on 29 out of the first 31 trial consulta-
tions. There were 10 patients in the guidelines arm, 11
patients in the implicit tool arm and 8 patients in the
explicit tool arm. We anticipated more subjects in the
explicit tool arm, however observed difficulties for
patients in understanding the standard gamble procedure
subsequently led to the explicit arm of the trial being dis-
continued prematurely [24].
Ethical approval for both the trial and the process study
was granted by the Newcastle and North Tyneside Local
Research Ethic Committee and research governance
approval by North Tyneside Primary Care Trust.
The process study was in three inter-linked parts:
(a) video-recording of consultations followed by a quan-
titative interaction analysis
(b) conversation analysis of consultations
(c) in-depth qualitative interview work with patients, 3
days and then three months after the consultation.
The detailed methods and results of (b) and (c) are
reported elsewhere [25,26] and this paper focuses on the
quantitative observational work (a).
The videos enabled non-participant observation of sub-
jects during the consultations. Twenty nine consultations
were video-recorded using an unmanned digital camera,
positioned so that the upper bodies of participants and
the decision-support tools were visible. Video-recordings
of the consultations were imported into the Observer soft-
ware to facilitate coding of verbal and non-verbal behav-
iour and later interaction analysis [27]. The audio-stream
of data was also fully transcribed to facilitate data coding.
Methodology
Interaction analysis is a systematic analysis of the clinical
encounter via identification, categorization and quantifi-
cation of salient features of doctor-patient communica-
tion [28]. The coding-frame for verbal behaviour was
based on the Medical Interaction Process System [MIPS]
[29], and the Roter Interaction Analysis System [RIAS]
[30], both well established protocols for clinical commu-
nication research [31]. Utterances, defined as the smallest
classifiable segment of speech [29,31], were the coding
unit for verbal behaviour. Utterances were coded by mode
of behaviour (e.g. open or closed questioning) and, where
appropriate, by content (e.g. medical, psychological or
social focus). Given the importance of non-verbal behav-
iour in communication [32], particularly in supporting
verbal behaviour [33], non-verbal codes were added to
the coding frame. These were initially derived from
observing six simulated GP-patient consultations, devel-
oped for training purposes, and cross-checked against
published work in this field [34-36].
The final version of the coding frame is appended [see
Additional file 1] and an explanatory manual is available
on request. Codes included 23 verbal modes of behaviour
(8 with content classification) which were coded as they
occurred. There were also 9 non-verbal activities which
were coded. Rapid activities (e.g. smiling or nodding)
were coded as they occurred whilst slower behaviour was
discontinuously coded at 1 minute sample intervals (Mar-
tin & Bateson 1986). Slow behaviour which could change
suddenly (e.g. gaze) was coded using 'one-zero sampling'
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in which any changes within the previous minute were
recorded. Slow and prolonged behaviour (e.g. posture)
was coded using 'instantaneous sampling' in which only
the behaviour occurring at the minute time-point was
recorded. Nonverbal behaviour involving touching or
pointing was classified as to whether it was directed at the
other person or the decision aid.
Data analysis
Analysis aimed to combine a broad overview of the con-
sultation (molar approach) with a detailed description of
a sampled section (molecular approach) of the consulta-
tion as recommended for communication research [31].
The overall duration of consultations was measured, as
was the duration of different phases within it [37]. These
phases included: opening activity (greeting and explana-
tory work); physical examination; presentation of risk
information; decision-making discussions; and closure
work. In addition, the duration of standard gamble proce-
dures was recorded in explicit decision aid consultations.
Due to the high volume of complex data available in vid-
eos, a section of the consultation was sampled for detailed
study. Henbest [38] found that scoring a section of con-
sultations can be as reliable as using the entire consulta-
tion. Moreover, a study of different sample-lengths found
that a 10-minute 'slice' was a reliable proxy for the entire
consultation for verbal and non-verbal behaviour [34,39].
Since the focus of the trial was decision-making, a ten-
minute 'slice' of activity leading up to the decision-point
was sampled for detailed analysis.
Verbal behaviour was collated into established meta-
groupings [40,41] [see Additional file 2] as recommended
for this type of research [42]. These meta-grouping make
intuitive sense of the behaviour, reduce the risk of multi-
ple comparison testing and enable comparison across
other studies in this field.
Finally, a measure of verbal dominance was calculated as
a percentage of all GP utterances divided by total GP +
patient utterances.
Reliability of coding
The reliability of data coding was established by intra and
inter-observer reliability statistics. Pearson's r correlations
at the 1% significance level for both reliability measures
were calculated for all behaviour categories with mean fre-
quency greater than 2. One researcher (BH) initially coded
all 29 consultations. For intra-observer reliability, the
same researcher recoded a one-minute random sample of
activity from the 29 consultations six-months after initial
coding. The overall average intra-observer correlation was
0.87; verbal behaviour had a mean correlation of 0.90
(range 0.87–0.93) and non-verbal behaviour had a mean
correlation of 0.83 (range 0.82–0.84). For inter-observer
reliability, a second researcher (TR) coded a one-minute
sample from the initial 29 'slices' of the consultation. The
overall average inter-observer correlation was 0.80; verbal
behaviour had a mean correlation of 0.81 (range 0.79–
0.82) and non-verbal behaviour had a mean correlation
of 0.80 (range 0.72–0.85).
Statistical issues
The analysis was intended to be primarily descriptive,
although statistical tests were used to enable comparison
across the three trial conditions (types of consultation).
Since the number of consultations was relatively small (n
= 29) and because the data were not normally distributed,
non-parametric statistics were used. Thus median sum-
mary values plus quartiles were reported. Statistical signif-
icance was set according to the convention level of P <
0.05.
Results
The median age of the 29 patients in the study was 72
years (quartiles 67–77), of which 13 were women
(median age 73, quartiles 69–79) and 16 were men
(median age 69, quartiles 66–73). There were no signifi-
cant differences in age or sex in the 3 trial groups. Most
patients (n = 24, 83%) entered the trial on warfarin med-
ication, three were taking aspirin and two were not on
treatment prior to the trial.
Consultation timing
Across all 29 consultations, the median consultation time
was 29 minutes (quartiles 20–43 minutes). There was a
significant difference in consultation times across the
three arms of the trial (Kruskal Wallis χ2 = 13.8, df 2, P =
0.001). The median consultation times were: 21 minutes
in the guidelines consultations (quartiles 19–26 min-
utes); 31 minutes in implicit tool consultations (quartiles
16–41 minutes); and 44 minutes in explicit tool consulta-
tions (quartiles 39–55 minutes). Within these consulta-
tions, there was a significant difference in timing of the
phases focused on risk assessment (Kruskal Wallis χ2 =
16.2, df 2, P < 0.001), decision-making (Kruskal Wallis χ2
= 8.3, df 2, P = 0.014) and closure (Kruskal Wallis χ2 =
16.2, df 2, P < 0.001). These three later phases were short-
est in consultations involving paper-based guidelines as
shown in Figure 1.
Table 1 shows the timings for individual patients in the
order that consultations occurred in the trial. Despite the
fact that one GP delivered each arm of the trial, there was
considerable variability both within and across the arms
of the trial. Thus each GP had longer and shorter consul-
tations. However, consultations involving computerised
decision aids were generally longer than those involving
paper-based guidelines. In addition, there were no obvi-
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Median duration of the different phases of the consultation shown in minutesFigure 1
Median duration of the different phases of the consultation shown in minutes.
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ous GP learning effects over time; that is, consultations
did not get shorter as a GP became more familiar with the
technology. It was clear that the standard-gamble proce-
dure of the explicit tool dominated the middle section of
consultations and extended their overall timescale. In
these 8 consultations, the standard gamble exercise took
up over a third of the entire consultation time (modal
value 35%) with a range of 28% to 51%.
Consultation content
In the 10 minutes immediately preceding the decision
point, GPs dominated the conversation with an overall
median verbal dominance score 64% (quartiles 58–66%).
GPs' verbal dominance across the trial arms was 60%
(quartiles 55–64) in the guidelines consultations; 65%
(quartiles 63–69) in the implicit tool consultations; and
64% (quartiles 60–66) in the explicit tool consultations.
These differences in verbal dominance across the trial
arms were not statistically significant (Kruskal Wallis χ2 =
4.7, df = 2, P = 0.09). Most of the GPs' conversation was
technical (93%) rather than socio-emotional (7%). For
patients, the respective proportions were 85% and 15%.
The tendency to focus on technical rather than socio-emo-
tional matters did not significantly differ across the three
arms of the trial, for GPs or patients.
The frequencies of different modes of verbal behaviour
shown by GPs and patients are presented in Table 2. Infor-
mation-giving was the dominant activity for both GPs and
patients, followed by paralinguistic registering of the
other persons' talk (e.g. uh huh). There was a significant
difference by trial arm in the frequency of information-
seeking by GPs which occurred least in implicit tool con-
sultations and in their conversational pauses which were
shown most in the guidelines consultations. For patients,
there was a significant difference by trial arm only in neg-
ative talk which occurred least in the implicit tool consul-
tations.
Frequencies of non-verbal behaviour shown by GPs and
patients are shown in Table 3. Head nodding, a common
way of indicating attention in conversation, was most fre-
quent activity for GPs and patients. For GPs, there was a
significant difference by trial arm in several non-verbal
activities: nodding, head-shaking, smiling, pointing at the
patient, touching or pointing at the decision aid and eye-
gaze directed towards the decision aid. In the guidelines
consultations, the GP showed the least nodding, smiling
and tool-directed eye-gaze but the most head-shaking and
pointing to patients. For patients, only tool-directed eye-
gaze differed by trial arm and this occurred least in guide-
lines consultations.
Discussion
All the consultations in this study took considerably
longer than the time usually available in primary care,
approximately ten minutes [43]. Thus it is unlikely that, in
their current form, the paper-based or computerised deci-
sion aids can be easily incorporated in GPs' routine con-
sultations. Centrally, both computerized versions of the
DARTS II tool prolonged the risk assessment and decision
making phases compared to paper-based guidelines.
These computerised decision aids were applied in the con-
text of shared-decision making and it has been noted that
actively involving patients in treatment decisions requires
additional time [44,45]. The computerised decision aids
also prolonged the closing phases of the consultation.
Reviewing the videos revealed that the GPs were often
engaged either in procedural work such as printing off
summary reports from the tool or in explaining the 'role'
of the computer in the consultation.
In the 10 minutes leading up to the decision point, infor-
mation-giving and technically-focused conversation dom-
inated proceedings. Although patients' talk was primarily
technical, it contained twice the socio-emotional content
of the GPs' conversation. Given that the socio-emotional
or affective component of clinicians' talk is a key factor in
patient's positive evaluation of consultations [46] and
subsequent adherence to treatment [47], it is essential to
establish if the use of technology encourages a shift
towards technical language at the expense of inter-per-
sonal work. Our results showed no significant difference
across the arms of the trial in the proportion of technical
to socio-emotional talk shown by GPs. Only the length of
time spent working through the tools differed. Thus the
technological complexity of the decision aid did not seem
to affect the balance of technical to socio-emotional lan-
guage used by GPs. However, future work should compare
the impact of decision aids (in any form) on the technical/
affective language balance compared to general consulta-
tion discourse.
What was consistent across all consultations in this study
was the large amount of information provided to patients
which tended to increase as the sophistication of the deci-
sion aids increased, albeit with a time cost. Overall, the
GPs in this study spent 55% of the consultation giving
information and 7% seeking it, which differs from the
average proportions of 35% and 23% reported in general
medical dialogue [41]. The patient proportions of 33%
and 7% in this study compare with 54% and 6% reported
elsewhere [41]. In this respect the decision aids appeared
to be useful tools in presenting patients with information,
suggesting that they might encourage an 'informed' model
of treatment decision-making [48] where the clinician
provides all the relevant information to patients who then
select the treatment they deem most appropriate [5].
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However, the enactment of 'shared' decision-making may
remain dependant on the GP/patient social interaction
and not directly shaped by technological decision aids.
It was clear that GPs in this study conversationally led the
consultation, contributing nearly two-thirds of all utter-
ances and showing more pauses within their speech than
patients. More powerful conversants generally talk for
longer and are allowed more uninterrupted pauses in
their speech [49]. The verbal dominance seen in this study
is similar to the average 60:40 ratio (doctor:patient)
reported in general medical dialogue [41]. Indeed we
observed no significant difference in verbal dominance, or
clear differences in verbal content, between the 'shared
decision making' consultations of the computerised deci-
sion aids and the 'paternalistic' consultations involving
paper-guidelines. This may appear counter-intuitive, in
that one might expect shared decision making consulta-
tions to have less verbal dominance than paternalistic
consultations. However, it may be that it takes considera-
ble verbal work from doctors to introduce and sustain any
model. In addition, such models do not just occur and an
initial intention to share may get lost in the unfolding
dynamic of the consultation [49], particularly where clini-
cians are tasked to work with and through a 'third party'
in the consultation, in the form of a decision aid.
GPs and patients both seemed behaviourally engaged in
these consultations, showing a great deal of paralinguistic
registering of the conversation [34]. There were a number
of significant differences in GP's nonverbal activity across
the arms of the trial but no consistent trends. Neverthe-
less, nonverbal activity appeared to be a key aspect of
communication and we found a great deal of mirroring in
eye-gaze and illustrative gesturing [49]. For example, on
one occasion a GP was attempting to explain atrial fibril-
lation to a patient and he used his hands to demonstrate
the pumping and fluttering action of the heart. Thus it is
Table 1: Timing of consultations and their phases in minutes
Patient Opening Examination Standard 
Gamble
Risk 
Assessment
Decision 
Making
Closure Total
Guidelines
1 4.2 10.2 n/a 3.5 1.2 0.9 20.0
2 3.0 16.2 n/a 3.5 1.4 1.6 25.7
3 2.6 10.7 n/a 2.9 1.2 1.0 18.4
4 4.6 14.5 n/a 4.0 3.4 0.8 27.3
5 3.4 9.3 n/a 5.2 10.1 0.3 28.3
6 2.0 10.9 n/a 3.5 1.6 0.8 18.8
7 6.9 9.4 n/a 1.1 1.8 0.4 19.6
8 3.1 11.4 n/a 2.9 5.3 1.7 24.4
9 3.3 14.0 n/a 3.4 0.7 0.6 22.0
10 2.4 8.4 n/a 4.7 1.8 2.9 20.2
Implicit
1 2.3 18.2 n/a 12.6 6.8 4.5 44.4
2 3.9 14.0 n/a 8.4 3.0 2.3 31.6
3 0.7 12.8 n/a 9.8 12.1 5.6 41.0
4 1.0 14.3 n/a 7.7 4.4 7.0 34.4
5 6.8 21.5 n/a 5.9 5.2 7.9 47.3
6 2.4 3.9 n/a 5.7 0.9 3.5 16.4
7 2.5 3.2 n/a 5.6 1.9 2.2 15.4
8 1.4 2.7 n/a 7.4 1.9 2.0 15.4
9 0.8 13.0 n/a 9.7 3.5 1.8 28.5
10 3.3 9.4 n/a 7.3 7.3 3.6 30.9
11 1.6 8.3 n/a 7.3 5.4 2.3 24.9
Explicit
1 2.5 1.4 21.9 9.7 2.4 5.0 42.9
2 1.1 10.4 14.3 8.9 8.1 8.8 51.6
3 1.6 6.6 13.2 6.5 7.6 2.5 38.0
4 2.0 7.0 19.0 5.1 7.7 2.4 43.2
5 3.1 14.1 20.9 3.4 9.1 5.6 56.2
6 2.7 9.4 25.9 4.6 7.5 9.1 59.2
7 4.6 10.6 16.0 5.2 6.9 1.7 45.0
8 1.3 9.6 10.5 3.1 2.0 3.1 29.6
Footnote: cases in each condition are in the order they occurred in the trial
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Table 2: Median frequency (quartiles) of verbal behaviour
Guidelines n = 10 Implicit n = 11 Explicit n = 8
Doctors
Information-giving 31 (27–39) 40 (37–57) 42 (31–47)
Information-seeking 6 (5–10) 3 (3–5) 7 (6–9)
Social talk 1 (0–1) 0 (0-0) 0 (0–1)
Positive talk 5 (3–9) 6 (2–10) 8 (6–9)
Negative talk 1 (0–1) 0 (0-0) 0 (0–1)
Partnership building 3 (3–4) 3 (1–5) 3 (2–5)
Registering other 18 (12–23) 9 (6–20) 20 (13–25)
Pause 6 (3–7) 4 (1–6) 1 (0–4)
Patients
Information-giving 17 (12–21) 16 (7–21) 14 (12–21)
Information-seeking 3 (1–5) 3 (2–3) 5 (2–9)
Social talk 1 (0–2) 0 (0–1) 0 (0–2)
Positive talk 12 (11–15) 7 (5–18) 12 (10–13)
Negative talk 2 (0–3) 0 (0–1) 1 (1–2)
Partnership building 0 (0–1) 0 (0-0) 0 (0–1)
Registering other 15 (6–23) 8 (2–18) 11 (7–25)
Pause 1 (1–4) 1 (0–1) 0 (0–1)
Footnote: Items in bold indicate statistically significant differences across the arms of the trial using Kruskal Wallis tests. Doctors'behaviour: 
Information seeking χ2 = 11.2, df 2, P < 0.004 and Pauses χ2 = 6.1, df 2, P < 0.04. Patients' behaviour: negative talk χ2 = 8.7, df 2, P < 0.01.
Table 3: Median frequency (quartiles) of non-verbal behaviour
Guidelines n = 10 Implicit n = 11 Explicit n = 8
Doctors
Nodding 17 (15–20) 36 (29–45) 21 (18–28)
Head shake 4 (2–5) 2 (1–3) 0 (0–1)
Smiling 0 (0-0) 1 (0–3) 2 (0–3)
Touching the patient 0 (0-0) 0 (0-0) 0 (0–1)
Pointing at the patient 1 (0–2) 0 (0-0) 0 (0-0)
Touching/pointing at tool 6 (3–8) 1 (1–4) 6 (4–12)
Hand gesturing (illustrative) 9 (4–15) 11 (4–21) 13 (4–15)
Eye-gaze towards patient 15 (12–18) 19 (16–20) 19 (17–20)
Eye-gaze towards tool 5 (3–7) 15 (14–19) 16 (16–18)
Position inclined to patient 1 (0–2) 0 (0–3) 0 (0–1)
Position inclined to tool 2 (0–4) 1 (0–2) 1 (0–2)
Patients
Nodding 21 (16–34) 31 (13–39) 19 (15–31)
Head shake 3 (1–6) 3 (2–7) 4 (2–7)
Smiling 2 (1–3) 0 (0–1) 1 (0–2)
Touching the doctor 0 (0-0) 0 (0-0) 0 (0-0)
Pointing at the doctor 0 (0–1) 0 (0-0) 0 (0-0)
Touching/pointing at tool 0 (0–1) 1 (0–3) 0 (0–1)
Hand gesturing (illustrative) 3 (2–7) 5 (3–10) 6 (2–7)
Eye-gaze towards doctor 15 (12–18) 19 (17–20) 17 (16–18)
Eye-gaze towards tool 5 (3–6) 16 (14–17) 16 (15–17)
Position inclined to doctor 1 (0–2) 0 (0–3) 0 (0–1)
Position incline to tool 2 (0–4) 1 (0–2) 1 (0–2)
Footnote: Items in bold indicate statistically significant differences across the arms of the trial using Kruskal Wallis tests. Doctors' behaviour: 
nodding χ2 = 10.5, df 2, p < 0.005; head shaking χ2 = 10.1, df 2, P < 0.006; smiling χ2 = 6.4, df 2, P = 0.04, pointing at the patient χ2 = 8.4, df 2, P = 
0.01 and touching/pointing at the decision aid χ2 = 10.0, df 2, P = 0.007 and eye-gaze towards the decision aid χ2 = 18.4, df 2, P < 0.001. Patients' 
behaviour : tool directed eye-gaze χ2 = 17.3, df 2, P < 0.0001.
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clear that unique information can be conveyed visually
[50]. Indeed it has been reported that just 7% of emo-
tional communication is conveyed verbally compared to
22% via voice tone and 55% through visual cues [32].
However, although non-verbal behaviour has long been
regarded to be an important feature of good communica-
tion [51] and an influence on medical outcomes such as
patient understanding, compliance and satisfaction with
care [52] it is much less well understood than verbal
behaviour [53]. Thus more attention should be focused
on identifying and understanding the contribution of
non-verbal behaviour to communication in clinical con-
texts.
Data limitations
Due to the exploratory nature of the process study, partic-
ularly the fact that each video-taped consultation was
linked to two subsequent in-depth interviews which was
highly labour intensive, the number of patients in this
observational analysis was relatively small. Moreover,
since the data were not normally distributed, we used con-
servative non-parametric statistics in our analysis, which
was intended to be primarily descriptive. Thus it is possi-
ble that real but small differences between the three types
of consultation were not detected which may have
emerged with a larger sample. Also the efficacy design of
the trial meant that just one GP delivered each decision
aid and so our findings may be confounded by GPs' style
in consultations rather than the decision aid per se. Nev-
ertheless, the GPs' verbal dominance and technical focus
was apparent across all the consultations on this study.
Although patients were randomised into the parent trial,
we used a convenience sample of the first 29 patients who
agreed to be videotaped (31 were asked). The trial eventu-
ally recruited 109 patients [54]. In addition, the earlier
recruits in our study are more likely to be prevalent cases
in the population with a longer experience of atrial fibril-
lation compared to later incident cases. Moreover, the
third arm of the trial (explicit version of DARTS II) was
discontinued after eight consultations as a result of data
produced by process study. We observed that a number of
patients found it difficult to understand the preference
elicitation exercise in these consultations and were
uncomfortable with this activity [24]. Thus this diver-
gence between the early process study and the final trial
clearly limits our ability to generalise findings from the
former to the latter. However, the relative lack of differ-
ences in patients' behaviour across the differing types of
consultations may help explain why the trial found only
transient effects of a computerised decision aid on
patients' decision conflict and no difference in actual
treatment decisions [54].
Due to the complexity of video-based data, a 10 minute
slice was sampled for detailed content analysis. The fact
that GPs in this study were so focused on information-giv-
ing may reflect the fact that conversational content varies
in different phases of a consultation [37] and this work
focused on the time just before the decision point. How-
ever, within the consultations promoting shared decision-
making this should have been the time when patients
were most actively involved in the conversation. We
found that they were much less vocal than the GPs at this
crucial time point.
In addition, consultation timing varied depending on
which decision aid was used and so the sampled 'slice' of
the consultation may have crossed differing sub-phases.
For instance, some physical examination work was
included in most time-samples from guidelines consulta-
tions, some from implicit tool consultations and none
from the explicit tool consultations. However, the lack of
clear differences in verbal behaviour between the trial
arms suggests that the latter did not strongly affect our
analysis.
Perhaps most importantly, the patients in this study were
also participants in a trial who had experienced extensive
consent procedures, who were not seeing their own GP
and who were attending an unfamiliar clinic. This context
may further explain the lack of differences in treatment
decisions reported by the trial [54]. Subsequent interview
work indicated that some participants regarded them-
selves as 'subjects' in a research study rather than 'real'
patients [26]. Moreover, conversation analysis of these
consultations revealed how the experimental context of
these consultations, at moments, overwhelmed the clini-
cal context of the interaction [25]. In this way, the impact
of the trial context on both patients and clinicians may
have outweighed any impact of the decision aids them-
selves. For patients, the eventual treatment decision may
not have been perceived as 'real' and for clinicians the
unfamiliar patients may have prompted less socio-emo-
tional language than usual and more conversational work
to maintain the dialogue.
Although the efficacy trial design (with high internal
validity) may limit the applicability of our process data to
the 'real world' of primary care, it is important to evaluate
the impact and acceptability of complex interventions,
such a decision aids, on a limited sample of patients (and
indeed clinicians) before wider scale roll out. The work in
this study revealed significant difficulties for patients with
the extended version of the DARTS II tool, despite earlier
pilot work. We also found that working with this decision
aid took clinicians and patients much longer than the
time usually available for consultations in primary care.
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Thus further development of this decision aid may be
required before the next evaluative stage which should
incorporate a more pragmatic (clinically representative)
study design.
Conclusion
This study showed clear differences in the duration of pri-
mary care consultations depending on the form of deci-
sion aid used. The use of paper-based guidelines took
twice the time usually available in primary care and com-
puterised decision aids took three or four times longer
than a standard consultation. Thus, unless specific clinics
are set aside for such work, it is unlikely that traditional or
technologically focused decision aids will be easily incor-
porated into routine primary care. Furthermore, even in
consultations aimed at promoting shared decision-mak-
ing, GPs were verbally dominant and more technically
focused than patients. Moreover despite differences in the
technological sophistication of the decision aids, we
found almost no difference in behaviour indicative of
shared decision-making across the trial arms. Responsibil-
ity for the enactment of a shared decision-making consul-
tation may therefore remain within the interactional
space between GP and patient. Decision aids may well be
closer to their designation than currently perceived;
optional resources which foster information transfer
rather than shared decision-making machines. Our data
showed the extensive use of these tools in presenting com-
plex information to the patient. However, we found no
clear evidence that they promoted the sharing of treat-
ment decisions.
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